Skip to main content
Back to RA Capital Management

RA Capital Management's Medical Portfolio

Browse 43 Medical companies funded by RA Capital Management. See funding amounts, founder contacts, and investment details.

Medical Companies
43
Total Funding in Medical
$4.4B

Medical Portfolio Companies (43)

Export
BiotechnologyHealth CareMedicalTherapeutics

Secretome Therapeutics is a clinical-stage cell therapy company that develops therapies for rare cardiac diseases.

Dallas, United States
May 2026
Series A

Founder Contacts

19,000+ verified contacts

BiotechnologyHealth CareMedicalTherapeutics

Q32 Bio is a biotechnology company that develops treatments for patients with severe autoimmune and inflammatory diseases.

Cambridge, United States
May 2026
Post-IPO Equity

Founder Contacts

19,000+ verified contacts

BiopharmaBiotechnologyLife ScienceMedicalWellness

Stipple Bio is a biotechnology company that offers cellular profiling and target discovery with epitope resolution.

Cambridge, United States
April 2026
Series A

Founder Contacts

19,000+ verified contacts

BiotechnologyHealth CareMedicalNeurosciencePharmaceutical

Climb Bio occurs when the immune system mistakenly attacks the body's tissues and can result in permanent organ damage or even death.

Redmond, United States
April 2026
Post-IPO Equity

Founder Contacts

19,000+ verified contacts

BiotechnologyHealth CareHealth DiagnosticsMedical

Adela creates develops technologies centered around detecting high-risk conditions like cancer through routine blood tests.

Foster City, United States
April 2026
$48.0M
Convertible Note

Founder Contacts

19,000+ verified contacts

BiotechnologyHealth CareMedicalTherapeutics

Adcendo is a biotech company that develops antibody-drug conjugates (ADCs) to target cancers with high unmet medical needs.

Copenhagen, Denmark
April 2026
$135.0M
Series C

Founder Contacts

19,000+ verified contacts

BiotechnologyGeneticsHealth CareMedical

Solid Biosciences is a life science company that conducts research for the treatment of Duchenne muscular dystrophy.

Charlestown, United States
March 2026
$240.0M
Post Ipo Equity

Founder Contacts

19,000+ verified contacts

BiotechnologyHealth CareMedical

Terrestrial Bio engages in developing biomedical innovations with a focus on improving access to vaccines.

Cambridge, United States
March 2026
$50.0M
Series C

Founder Contacts

19,000+ verified contacts

BiotechnologyLife ScienceMedicalPharmaceutical

Hemab is a clinical-stage biotech company that develops prophylactic biologic therapies for underserved bleeding and thrombotic.

Copenhagen, Denmark
October 2025
$157.0M
Series C

Founder Contacts

19,000+ verified contacts

BiotechnologyMedicalMedical DeviceTherapeutics

VitriVax is a formulation technology company that engineers solutions to maximize the accessibility and utility of human vaccines.

Boulder, United States
October 2025
$17.3M
Series B

Founder Contacts

19,000+ verified contacts

BiopharmaBiotechnologyMedical

Indapta Therapeutics is a privately held biotechnology company.

San Francisco, United States
October 2025
$50.8M
Venture - Series Unknown

Founder Contacts

19,000+ verified contacts

Health CareMedicalTherapeutics

Star Therapeutics mission is to develop therapies for as many diseases as possible for millions of patients.

South San Francisco, United States
September 2025
$125.0M
Series D

Founder Contacts

19,000+ verified contacts

BiotechnologyMedicalPharmaceutical

Alchemab Therapeutics is developing protective antibodies designed to keep people free of hard-to-treat diseases.

London, United Kingdom
September 2025
$32.0M
Series A

Founder Contacts

19,000+ verified contacts

DeliveryMedicalPharmaceutical

Spyglass Pharma provides medicine for ophthalmic diseases.

Aliso Viejo, United States
June 2025
$75.0M
Series D

Founder Contacts

19,000+ verified contacts

BiotechnologyHealth CareMedical

Vaxess Technologies engages in developing biomedical innovations with a focus on improving access to vaccines.

Cambridge, United States
April 2025
$9.0M
Venture - Series Unknown

Founder Contacts

19,000+ verified contacts

BiotechnologyHealth CareMedicalTherapeutics

Vivace Therapeutics is a venture-backed start-up dedicated to discovering and developing cancer therapeutics by targeting a novel pathway.

San Mateo, United States
March 2025
$35.0M
Series D

Founder Contacts

19,000+ verified contacts

BiotechnologyHealth CareLife ScienceMedical

Bambusa Therapeutics operates as biotechnology company.

Boston, United States
February 2025
$90.0M
Series A

Founder Contacts

19,000+ verified contacts

BiotechnologyMedicalProduct Research

AmbAgon Therapeutics is a developer of cancer molecule therapeutics.

San Francisco, United States
February 2025
$5.0M
Venture - Series Unknown

Founder Contacts

19,000+ verified contacts

Health CareMedicalNeuroscienceWellness

We provide neurodegenerative disease patients with expert MDs and 24/7 wrap around care, no matter where you live in the US

Chicago, United States
November 2024
$25.0M
Series A

Founder Contacts

19,000+ verified contacts

Clinical TrialsHealth CareMedical Device

Innoventric, a start-up company from Ness-Ziona, Israel, develops the unique Trillium technology

Ness Ziona, Israel
October 2024
$28.5M
Series B

Founder Contacts

19,000+ verified contacts

Health CareMedicalPharmaceutical

Convergent Therapeutics is a pharmaceutical company that focuses on developing radiopharmaceutical therapies for prostate cancer.

Cambridge, United States
September 2024
$40.0M
Series A

Founder Contacts

19,000+ verified contacts

BiotechnologyMedicalPharmaceutical

Superluminal Medicines is a generative biological and chemical company that innovates drug discovery and development processes.

Boston, United States
September 2024
$120.0M
Series A

Founder Contacts

19,000+ verified contacts

BiotechnologyMedicalTherapeutics

Halda Therapeutics is a research-stage drug discovery company.

New Haven, United States
August 2024
$126.0M
Series B

Founder Contacts

19,000+ verified contacts

BiotechnologyLife ScienceMedicalTherapeutics

Bright Peak is a biotech company that develops a portfolio of immunotherapies for the treatment of cancer and autoimmune diseases.

Allschwil, Switzerland
June 2024
$90.0M
Series C

Founder Contacts

19,000+ verified contacts

BiotechnologyLife ScienceMedical

Ajax Therapeutics is a biotechnology company developing therapies to target cytokine signaling pathways that drive hematologic malignancies.

Cambridge, United States
May 2024
$95.0M
Series C

Founder Contacts

19,000+ verified contacts

BiopharmaBiotechnologyMedicalTherapeutics

Rampart Bioscience develops gene medicines to provide long-lasting treatments for a wide range of diseases.

La Jolla, United States
October 2023
$85.0M
Series A

Founder Contacts

19,000+ verified contacts

Health CareMedicalWellness

Ventricle Health offers evidence-based therapy, remote patient monitoring, patient education, and advocacy services for cardiac care.

Greensboro, United States
October 2023
$8.0M
Seed

Founder Contacts

19,000+ verified contacts

BiotechnologyLife ScienceMedical

Capacity Bio is a therapeutics company that is focused on mitophagy.

Palo Alto, United States
March 2023
$35.0M
Series A

Founder Contacts

19,000+ verified contacts

BiopharmaBiotechnologyLife ScienceMedicalTherapeutics

Diagonal Therapeutics is a biotechnology startup that develops targeted therapies for cancer and genetic diseases.

Watertown, United States
January 2026
$125.0M
Series B

Founder Contacts

19,000+ verified contacts

BiopharmaBiotechnologyHealth CareLife ScienceMedicalPharmaceuticalPrecision Medicine

Parabilis Medicines is a Grupo Bugio is a biopharmaceutical firm that specializes in creating medicines.

Cambridge, United States
January 2026
$305.0M
Series F

Founder Contacts

19,000+ verified contacts

BiotechnologyInformation TechnologyMedicalProduct Research

Azalea Therapeutics is a biotechnology company with a primary focus on developing cancer immunotherapies.

Berkeley, United States
November 2025
$65.0M
Series A

Founder Contacts

19,000+ verified contacts

BiopharmaBiotechnologyMedical Device

Artios Pharma is a biopharmaceutical company that provides new solutions in the DNA damage response (DDR) field.

Cambridge, United Kingdom
November 2025
$115.0M
Series D

Founder Contacts

19,000+ verified contacts

Health CareMedicalTherapeutics

Kinaset Therapeutics is a biopharma company that focuses on advancement of novel drugs in areas of unmet medical needs.

Boston, United States
January 2026
$103.0M
Series B

Founder Contacts

19,000+ verified contacts

BiopharmaBiotechnologyLife ScienceMedical

Zura Bio is a clinical-stage, multi-asset biotechnology company.

Henderson, United States
February 2026
$125.0M
Post Ipo Equity

Founder Contacts

19,000+ verified contacts

BiotechnologyMedicalTherapeutics

Slate Medicines develops therapeutics that target Pituitary Adenylate Cyclase-Activating Polypeptide for migraine treatment and prevention.

Raleigh, United States
February 2026
$130.0M
Series A

Founder Contacts

19,000+ verified contacts

BiotechnologyLife ScienceMedicalTherapeutics

Immunic is a biopharmaceutical company that develops a pipeline of selective oral immunology therapies.

New York, United States
February 2026
$400.0M
Post Ipo Equity

Founder Contacts

19,000+ verified contacts

BiotechnologyHealth CareMedicalOncologyTherapeutics

Coherus Biosciences develops, manufactures, and commercializes biologic therapeutics for oncology and inflammatory diseases.

Redwood City, United States
February 2026
$50.1M
Post Ipo Equity

Founder Contacts

19,000+ verified contacts

BiopharmaBiotechnologyHealth CareMedical

Angitia Biopharmaceuticals develops biologic therapies for musculoskeletal diseases.

Westlake Village, United States
February 2026
$130.0M
Series D

Founder Contacts

19,000+ verified contacts

BiotechnologyHealth CareMedical

CORXEL Pharmaceuticals is a biotechnology company that develops science and medicines for underserved patients.

Shanghai, China
January 2026
$287.0M
Series D

Founder Contacts

19,000+ verified contacts

BiotechnologyMedicalTherapeutics

Ambros Therapeutics is a clinical-stage biotechnology company.

Irvine, United States
December 2025
$125.0M
Series A

Founder Contacts

19,000+ verified contacts

BiotechnologyHealth CareMedicalPharmaceutical

Dyne Therapeutics is a developer of targeted therapies intended for serious muscle diseases.

Cambridge, United States
December 2025
$402.5M
Post Ipo Equity

Founder Contacts

19,000+ verified contacts

GeneticsHealth CareMedical

Sidera Bio harness human genetics, that helps in transformative medicines for patients.

Copenhagen, Denmark
December 2025
$109.0M
Series A

Founder Contacts

19,000+ verified contacts

BiotechnologyHealth CareMedicalTherapeutics

Tango Therapeutics is a biotechnology company that is developing next generation cancer therapies.

Cambridge, United States
October 2025
$197.0M
Post Ipo Equity

Founder Contacts

19,000+ verified contacts

Explore RA Capital Management's Full Portfolio

View all companies funded by RA Capital Management across every industry and funding stage.

View Full RA Capital Management Portfolio